Who Paid My Doc
Obizur
Biological Hematology
NDC 0944-5001-01
General payments
$11,805,487
Research payments
$241,932
Through program year 2025, $11,805,487 in general payments and $241,932 in research payments were reported against Obizur (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,893,129 | 4 |
| 2024 | General | $1,661,539 | 5 |
| 2023 | General | $1,431,330 | 3 |
| 2022 | General | $1,704,914 | 9 |
| 2022 | Research | $44,333 | 18 |
| 2021 | General | $1,745,885 | 30 |
| 2021 | Research | $19,889 | 17 |
| 2020 | General | $1,334,425 | 16 |
| 2020 | Research | $126,080 | 68 |
| 2019 | General | $2,034,265 | 86 |
| 2019 | Research | $51,630 | 44 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
153 general · 147 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.